Vimarsana
Biggest News Aggregation in the World

Page 18 - Michael Abrams News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Michael Abrams. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Michael Abrams Today - Breaking & Trending Today

Dedicated HCPCS Billing Code for Arch Therapeutics' AC5® - Vimarsana News

Dedicated HCPCS Billing Code for Arch Therapeutics' AC5®

New code is expected to advance commercialization efforts in doctors’ offices and other outpatient settings...

Hospitals brace for more patients who can't pay, Moody's says - Vimarsana News

Hospitals brace for more patients who can't pay, Moody's says

Millions of Americans are likely to lose Medicaid coverage this year. That's bad news for hospitals as well as patients. Hospitals will likely see bad debt soar when a pandemic-era rule expires allow...

Source: theday.com
Hospital debt rise likely as rule ends - Vimarsana News

Hospital debt rise likely as rule ends

Hospitals will likely see bad debt soar when a pandemic-era rule expires allowing states to kick patients off Medicaid April 1, according to a January report from Moody's Investors Service. The rule had encouraged states to keep beneficiaries continuously enrolled -- regardless of eligibility -- to receive higher reimbursements. Once states start trimming their rolls, however, hospital revenue is expected to decline as health-care providers will need to assume costs from an expected wave of uninsured patients.

eCommerce Revenues Continue to Surge as Consumers Limit In-Store Purchases - Vimarsana News

eCommerce Revenues Continue to Surge as Consumers Limit In-Store Purchases

/PRNewswire/ -- FinancialNewsMedia.com News Commentary - eCommerce sales for businesses have been steadily increasing for years, and with the migration of...

Pulse Oximeters Need to Work Better for Dark-Skinned Patients, FDA Panel Says - Vimarsana News

Pulse Oximeters Need to Work Better for Dark-Skinned Patients, FDA Panel Says

Warnings to patients and providers, improved accuracy needed, advisors say